A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International journal of pharmaceutics

• Publication date

  2014-10-01

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1016/j.ijpharm.2014.06.022PMID 24999055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SOLID LIPID NANOPARTICLES: A REVIEW

  2017cited by this paper
• Controlled polymorphic transformation of continuously crystallized solid lipid nanoparticles in a microstructured device: a feasibility study.

  2014cited by this paper
• HIV-1 RNA processing as therapeutic target: characterization of small molecule modulators of HIV-1 RNA processing and transport

  2013cited by this paper
• Transcription elongation regulator 1 (TCERG1) regulates competent RNA polymerase II-mediated elongation of HIV-1 transcription and facilitates efficient viral replication

  2013cited by this paper
• Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector.

  2013cited by this paper
• High melting lipid based approach for drug delivery: solid lipid nanoparticles.

  2013cited by this paper
• Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA.

  2012cited by this paper
• Functional coupling of transcription and splicing.

  2012cited by this paper
• Cellular delivery of cationic lipid nanoparticle-based SMAD3 antisense oligonucleotides for the inhibition of collagen production in keloid fibroblasts.

  2012cited by this paper
• TCERG1 Regulates Alternative Splicing of the Bcl-x Gene by Modulating the Rate of RNA Polymerase II Transcription

  2011cited by this paper
• Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles.

  2011cited by this paper
• Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA.

  2011cited by this paper
• Structural properties of solid lipid based colloidal drug delivery systems

  2011cited by this paper
• Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies.

  2011cited by this paper
• Cytotoxicity effect of solid lipid nanoparticles on human breast cancer cell lines

  2011cited by this paper
• pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.

  2010cited by this paper
• Differential Effects of Sumoylation on Transcription and Alternative Splicing by Transcription Elongation Regulator 1 (TCERG1)*

  2010cited by this paper
• Identification of the Cellular Targets of the Transcription Factor TCERG1 Reveals a Prevalent Role in mRNA Processing*

  2008cited by this paper
• Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.

  2008cited by this paper
• Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.

  2007cited by this paper
• The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing.

  2007cited by this paper
• Human Transcription Elongation Factor CA150 Localizes to Splicing Factor-Rich Nuclear Speckles and Assembles Transcription and Splicing Components into Complexes through Its Amino and Carboxyl Regions

  2006cited by this paper
• CA150 Expression Delays Striatal Cell Death in Overexpression and Knock-In Conditions for Mutant Huntingtin Neurotoxicity

  2006cited by this paper
• Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands.

  2006cited by this paper
• Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer.

  2004cited by this paper
• The WW Domain-Containing Proteins Interact with the Early Spliceosome and Participate in Pre-mRNA Splicing In Vivo

  2004cited by this paper
• Application of Novel Solid Lipid Nanoparticle (SLN)-Gene Vector Formulations Based on a Dimeric HIV-1 TAT-Peptide in Vitro and in Vivo

  2004cited by this paper
• FF Domains of CA150 Bind Transcription and Splicing Factors through Multiple Weak Interactions

  2004cited by this paper
• The production and characteristics of solid lipid nanoparticles (SLNs).

  2003cited by this paper
• Preparation and purification of cationic solid lipid nanospheres--effects on particle size, physical stability and cell toxicity.

  2003cited by this paper
• The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis.

  2001cited by this paper
• Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA.

  2001cited by this paper
• Solid lipid nanoparticles: production, characterization and applications.

  2001cited by this paper
• Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing.

  2001cited by this paper
• Microemulsion-based media as novel drug delivery systems

  2000cited by this paper
• Microemulsion-based media as novel drug delivery systems.

  2000cited by this paper
• Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

  2000cited by this paper
• CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription

  1997cited by this paper
• Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN).

  1997cited by this paper
• Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid (*)

  1995cited by this paper

• Development and Characterization of Lyophilized Chondroitin Sulfate-Loaded Solid Lipid Nanoparticles: Encapsulation Efficiency and Stability

  2025cites this paper
• Current advances in non-viral nanoparticle-based gene therapy for effective management of cancer

  2024cites this paper
• Development of cationic solid lipid nanoparticles incorporating cholesteryl-9-carboxynonanoate (9CCN) for delivery of antagomiRs to macrophages.

  2024cites this paper
• Lipid-based Non-viral Vector: Promising Approach for Gene Delivery.

  2024cites this paper
• Comparative Analysis of the Physicochemical and Biological Characteristics of Freeze-Dried PEGylated Cationic Solid Lipid Nanoparticles

  2023cites this paper
• Nanotechnology in stem cell research and therapy

  2022cites this paper
• Regeneration of insulin-producing cells from iPS cells using functionalized scaffolds and solid lipid nanoparticles

  2022cites this paper
• Solid Lipid Nanoparticles-Based Drug and Gene Delivery to Macrophages

  2022cites this paper
• 3-Hydroxyhexanoate-based polycationic nanoparticle system for delivering reprogramming factors

  2020cites this paper
• Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects

  2020cites this paper
• Application of computational tools for the designing of Oleuropein loaded nanostructured lipid carrier for brain targeting through nasal route

  2019cites this paper
• PRELIMINARY CHARACTERIZATION OF MODIFIED NANOSTRUCTURED LIPID CARRIERS AS POTENTIAL DRUG DELIVERY SYSTEMS

  2019cites this paper
• Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy

  2019cites this paper
• Improved synthesis and characterization of cholesteryl oleate-loaded cationic solid lipid nanoparticles with high transfection efficiency for gene therapy applications.

  2019cites this paper
• Development of protocol for screening of formulation attributes and the assessment of common quality problems in oleuropein loaded nanostructured lipid carriers

  2019cites this paper
• Will Nanotechnology Bring New Hope for Stem Cell Therapy?

  2019cites this paper
• Preparation, characterization and evaluation of solid lipid nanoparticles and niosomes for ING4 gene delivery to MCF-7 cells

  2019cites this paper
• Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system.

  2019cites this paper
• Topical delivery of TRPsiRNA-loaded solid lipid nanoparticles confer reduced pain sensation via TRPV1 silencing, in rats

  2018cites this paper
• Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy

  2018cites this paper
• Preparation and characterization of non-viral gene delivery systems with pEGFP-C1 Plasmid DNA

  2018cites this paper
• Functional and in vitro gastric digestibility of the whey protein hydrogel loaded with nanostructured lipid carriers and gelled via citric acid-mediated crosslinking.

  2017cites this paper
• Surfactant effect on the physicochemical characteristics of cationic solid lipid nanoparticles.

  2017cites this paper
• Drug Vectoring Systems To Target Drug Delivery Using Nanotechnologies

  2017cites this paper
• DNA/RNA-based formulations for treatment of breast cancer

  2017cites this paper
• Improved formulation of cationic solid lipid nanoparticles displays cellular uptake and biological activity of nucleic acids.

  2017cites this paper
• Powering up the molecular therapy of RNA interference by novel nanoparticles.

  2016cites this paper
• Cationic Nanoparticles Assembled from Natural-Based Steroid Lipid for Improved Intracellular Transport of siRNA and pDNA

  2016cites this paper
• Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.

  2016cites this paper
• Cytoprotective effects against UVA and physical properties of luteolin-loaded cationic solid lipid nanoparticle

  2016cites this paper
• Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems

  2016cites this paper
• How Lipid Cores Affect Lipid Nanoparticles as Drug and Gene Delivery Systems

  2016cites this paper
• Nanoparticles in Vaccine Development

  2015cites this paper
• A novel reduction-sensitive modified polyethylenimine oligonucleotide vector.

  2015cites this paper
• The effects of size and surface modification of amorphous silica particles on biodistribution and liver metabolism in mice

  2015cites this paper
• Self-assembling systems based on quaternized derivatives of 1,4-diazabicyclo[2.2.2]octane in nutrient broth as antimicrobial agents and carriers for hydrophobic drugs.

  2015cites this paper
• Mechanism Study of Gene Delivery and Expression in PK-15 Cells Using Magnetic Iron Oxide Nanoparticles as Gene Carriers

  2014cites this paper